Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge.

[1]  P. Foster,et al.  Chemokines in asthma: cooperative interaction between chemokines and IL-13. , 2003, The Journal of allergy and clinical immunology.

[2]  D. Taub,et al.  Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. , 2002, Blood.

[3]  Lin Ying Liu,et al.  Decreased Expression of Membrane IL-5 Receptor α on Human Eosinophils: I. Loss of Membrane IL-5 Receptor α on Airway Eosinophils and Increased Soluble IL-5 Receptor α in the Airway After Allergen Challenge1 , 2002, The Journal of Immunology.

[4]  Dominique Schols,et al.  AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. , 2002, The American journal of pathology.

[5]  R. Geha,et al.  CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. , 2002, The Journal of clinical investigation.

[6]  D. Friend,et al.  The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Ohta,et al.  Chemokine receptor expression profile of eosinophils at inflamed tissue sites: Decreased CCR3 and increased CXCR4 expression by lung eosinophils. , 2001, The Journal of allergy and clinical immunology.

[8]  A. Kaser,et al.  Functional expression of chemokine receptor 2 by normal human eosinophils. , 2001, The Journal of allergy and clinical immunology.

[9]  S. Lira,et al.  Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation , 2001, The Journal of experimental medicine.

[10]  E. Israel,et al.  Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. , 2001, American journal of respiratory and critical care medicine.

[11]  R. Breuer,et al.  Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. , 2001, American journal of respiratory cell and molecular biology.

[12]  C. Bandeira‐Melo,et al.  Eotaxins. Contributing to the diversity of eosinophil recruitment and activation. , 2001, American journal of respiratory cell and molecular biology.

[13]  Y. Kato,et al.  Chemokines induce eosinophil degranulation through CCR-3. , 2000, The Journal of allergy and clinical immunology.

[14]  W. Busse,et al.  Inhaled budesonide decreases airway inflammatory response to allergen. , 2000, American journal of respiratory and critical care medicine.

[15]  Sha Quan,et al.  CXCR3 Expression and Activation of Eosinophils: Role of IFN-γ-Inducible Protein-10 and Monokine Induced by IFN-γ1 , 2000, The Journal of Immunology.

[16]  Kazuhiko Yamamoto,et al.  Expression of CXCR4 in Eosinophils: Functional Analyses and Cytokine-Mediated Regulation1 , 2000, The Journal of Immunology.

[17]  C. Murdoch,et al.  Chemokine receptors and their role in inflammation and infectious diseases. , 2000, Blood.

[18]  P. Weller,et al.  Lymph node trafficking and antigen presentation by endobronchial eosinophils. , 2000, The Journal of clinical investigation.

[19]  R. Nickel,et al.  Chemokines and allergic disease. , 1999, The Journal of allergy and clinical immunology.

[20]  K. Ohta,et al.  Eosinophil chemotaxis by chemokines: a study by a simple photometric assay , 1999, Allergy.

[21]  I. Pavord,et al.  Increases in eotaxin‐positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge , 1999, Allergy.

[22]  M. Rothenberg,et al.  CC Chemokine Receptor-3 Undergoes Prolonged Ligand-induced Internalization* , 1999, The Journal of Biological Chemistry.

[23]  S. Bel,et al.  Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. , 1999, Journal of immunology.

[24]  O. Götze,et al.  The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils , 1999 .

[25]  A. Bellini,et al.  Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation , 1998, Clinical and experimental immunology.

[26]  S. Holgate,et al.  Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. , 1997, American journal of respiratory and critical care medicine.

[27]  C. Mackay,et al.  Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. , 1997, The Journal of clinical investigation.

[28]  H. Kita,et al.  Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge. , 1996, The Journal of allergy and clinical immunology.

[29]  J. Demartino,et al.  Cloning, expression, and characterization of the human eosinophil eotaxin receptor , 1996, The Journal of experimental medicine.

[30]  E. Butcher,et al.  L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. , 1994, Journal of immunology.

[31]  P. Zanen,et al.  RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. , 1994, Blood.

[32]  W. Busse,et al.  Increased airway inflammation with segmental versus aerosol antigen challenge. , 1993, The American review of respiratory disease.